Moreover, Li et al. further elucidate that knocking down METTL14 and NSUN2 in OS cells can respectively potentiate the inhibitory effects of ATRA and doxorubicin on tumors, thereby suppressing tumor drug resistance 11, 132. The gene discussed is NSUN2; the disease is neoplasm.